Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Annia Gorte"'
Autor:
Henrry Diaz, Jorge Jiménez, Aray Hernández, Leivis Valdés, Ariadna Martínez, Leonor Porto, Raity Hernández, Nadina Travieso, Julio Héctor Jova, Loipa Medel, Mayelin Troche, Annia Gorte, Delmis Batista, Ana Rosa Valls, Leticia Cabrera, Milagros Domeq, Leslie Pérez, Patricia Lorenzo-Luaces, Lizet Sánchez, Danay Saavedra, Mayra Ramos, Tania Crombet
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
EGFR signaling is an important regulator of SARS-CoV induced lung damage, inflammation and fibrosis. Nimotuzumab is a humanized anti-EGFR antibody registered for several cancer indications. An expanded access study was conducted to evaluate the safet
Externí odkaz:
https://doaj.org/article/448cc783b2114a2ca0706994779c5ed5
Autor:
Sayly Alfonso, Yuliannis Santiesteban, Daymys Estevez, Annia Gorte, Jessica García-Viamontes, Raiza Ruiz-Lorente, Mayra Ramos-Suzarte, Meylan Cepeda, Carmen Viada, Mayelin Troche, Erasmo Mendoza, Eduardo Santiesteban, Leticia Cabrera, Ana Rosa Vals, Ihosvannys Carreño, Conrado Ramos Mico, Kirenia Camacho, Milagros Domenech, Ramón Ortiz, Delmis Batista, Yanela Santiesteban, Yamilka Sánchez
Publikováno v:
Journal of Cancer Therapy. 12:146-156
Cervical uterine cancer represents the fourth most common malignant neoplasm worldwide in the female sex in terms of incidence, principally from epithelial origen. The high expression of EGFR in this tumor leads to the search for therapeutic alternat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cae5dbf34566a32a70f5dd8f2715456
https://doi.org/10.4236/jct.2021.123016
https://doi.org/10.4236/jct.2021.123016
Autor:
Eduardo Ibañez, Annia Gorte, Kirenia Camacho, Zaima Mazorra, Patricia Lorenzo-Luaces, Amnely González, Eduardo Santiesteban, Tania Crombet, Laura Martínez, Rosa Maria Amador, Victor Manuel Medina, Danay Saavedra, Meylan Cepeda, Leticia Cabrera, Yuliannis Santiesteban, Pedro C. Rodriguez, Jenysbel de la Caridad Hernández, M. Hernandez, Yanet Caveda
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Bladder cancer is the ninth most common malignancy worldwide and the seventh in male patients. Most of new patients are diagnosed with non-muscle invasive bladder cancer. It usually courses with a favorable prognosis, although there is a high risk of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::530d4e8803650263bf1cb60e655e6886
https://doi.org/10.26502/jcsct.5079096
https://doi.org/10.26502/jcsct.5079096